Continue reading here: Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
Continue reading here: Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
Read more: Recce Pharmaceuticals Provides Additional Positive Update on Patients Treated Under “Special Access Scheme”
Continued here: PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright...
View original post here: CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
See the article here: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Visit link: Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of...
Go here to read the rest: Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
See the original post here: Nexcella Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of...
Read the rest here: Umoja Biopharma’s VivoVec Platform Presents Encouraging Proof-of-Concept Data in Ongoing Non-Human Primate Study at the 8th CAR-TCR Summit
Read the original: Monthly Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of August 31, 2023
Recent Comments